Skip to main content
Clinical Trials/TCTR20240715014
TCTR20240715014
Completed
Phase 3

Platelet rich plasma therapy in decrease post operative tonsillectomy pain and bleeding

HRH princess MaHa Chakri Sirindhorn Medical center0 sites30 target enrollmentJuly 15, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
post-operative tonsillectomy pain and bleeding
Sponsor
HRH princess MaHa Chakri Sirindhorn Medical center
Enrollment
30
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 15, 2024
End Date
August 30, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Age 18\-60 years
  • 2\.The participants must have met the indication for tonsillectomy

Exclusion Criteria

  • 1\. Have underlying disease
  • 2\. The participants have contraindication for platelet\-rich plasma (abnormal platelet and coagulation profiles)
  • 3\.The participants take antiplatelet medication
  • 4\.Immunocompromised host
  • 5\.Suspected cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials